Many people wish they could forget this year, but not Novavax (NASDAQ:NVAX). It reported great news for its flu vaccine candidate NanoFlu earlier in 2020. Novavax has also emerged as the biggest coronavirus vaccine winner so far, at least in stock performance.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,